Paushak

Why is Paushak Ltd falling/rising?

As of 03-Aug, Paushak Ltd's stock price is rising to 651.50, up 3.49%, driven by strong performance compared to the Sensex and increased investor interest. The stock has gained consistently over the past days and is trading above key moving averages, indicating robust momentum.

As of 03-Aug, Paushak Ltd's stock price is rising, currently at 651.50, reflecting an increase of 21.95 or 3.49%. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 13.78% compared to the Sensex's 2.35%. Additionally, in the last month, Paushak Ltd has seen a return of 19.51%, significantly higher than the Sensex's 1.13%.<BR><BR>Today, the stock opened with a gain of 3.25% and reached an intraday high of Rs 660.2, marking a rise of 4.87%. The stock has been on a positive trajectory, gaining for three consecutive days and achieving a total return of 12.8% during this period. Furthermore, Paushak Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong momentum.<BR><BR>Investor interest appears to be increasing, as evidenced by a significant rise in delivery volume, which increased by 312.7% compared to the 5-day average. The sector in which Paushak operates, Pesticides & Agrochemicals, has also shown positive performance, gaining 2.21%. These factors collectively contribute to the stock's rising price.

Which are the latest news on Paushak?

Should I buy, sell or hold Paushak Ltd?

Are Paushak Ltd latest results good or bad?

Paushak Ltd's latest results show strong revenue growth of 51.52% quarter-on-quarter, reaching ₹83.55 crores, but profitability concerns arise with a net profit decline of 20.70% year-on-year and a reduced PAT margin of 18.07%. While sales are robust, the company faces challenges with rising costs and operational efficiency that could impact future growth.

Paushak Ltd's latest results present a mixed picture. On one hand, the company achieved a significant revenue surge of 51.52% quarter-on-quarter, reaching ₹83.55 crores, which is the highest quarterly sales in its recent history. This strong top-line growth indicates robust demand for its specialty chemicals, particularly in isocyanates, chloroformates, and carbamates.<BR><BR>However, this impressive revenue growth comes with notable concerns regarding profitability. The net profit for the quarter was ₹15.10 crores, reflecting a quarter-on-quarter increase of 25.49%, but a year-on-year decline of 20.70%. Furthermore, the profit after tax (PAT) margin has contracted sharply to 18.07%, down from 21.53% a year ago, indicating that rising input costs or operational inefficiencies are impacting the bottom line.<BR><BR>Additionally, while the operating margin improved slightly to 30.70% from the previous quarter, it is still down from 31.94% a year earlier. The company's return on equity (ROE) and return on capital employed (ROCE) metrics are also below industry averages, raising concerns about capital efficiency.<BR><BR>Overall, while the revenue performance is strong, the simultaneous margin compression and declining profitability metrics suggest that the company's growth may not be sustainable without addressing these operational challenges. Investors may need to weigh these factors carefully when considering the company's future prospects.

When is the next results date for Paushak Ltd?

The next results date for Paushak Ltd is 30 July 2026.

The next results date for Paushak Ltd is scheduled for 30 July 2026.

How big is Paushak?

As of 10th June, Paushak Ltd has a market capitalization of 1,172.00 Cr, with recent net sales of 218.60 Cr and net profit of 39.32 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Paushak Ltd has a market capitalization of 1,172.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 218.60 Cr, while the sum of Net Profit for the same period is 39.32 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 465.49 Cr, and Total Assets amount to 571.98 Cr.

Who are in the management team of Paushak?

The management team of Paushak includes Chirayu R Amin (Chairman), Udit C Amin, Amit M Goradia, Vijay H Gandhi, Abhijit A Joshi (CEO), Atul Patel, Roopa Patel, and Tushar Arvindbhai Shah, combining both executive and independent directors for effective governance.

The management team of Paushak includes the following individuals:<BR><BR>1. **Chirayu R Amin** - Chairman (Non-Executive)<BR>2. **Udit C Amin** - Non-Executive & Non-Independent Director<BR>3. **Amit M Goradia** - Non-Executive & Independent Director<BR>4. **Vijay H Gandhi** - Non-Executive & Independent Director<BR>5. **Abhijit A Joshi** - Whole Time Director & CEO<BR>6. **Atul Patel** - Non-Executive & Independent Director<BR>7. **Roopa Patel** - Independent Director<BR>8. **Tushar Arvindbhai Shah** - Independent Director<BR><BR>This team brings a mix of executive and independent perspectives to the company's governance.

Who are the peers of the Paushak?

Paushak's peers include S H Kelkar & Co., Vidhi Specialty, Indokem, Nitta Gelatin, Platinum Industries, Excel Industries, Oriental Aromatics, Sunshield Chemicals, Jyoti Resins, and Indo Amines. In terms of management risk, growth, and capital structure, Paushak is rated average, with a 1-year return of -14.34%.

Peers: The peers of Paushak are S H Kelkar & Co., Vidhi Specialty, Indokem, Nitta Gelatin, Platinum Industr, Excel Industries, Oriental Aromat., Sunshield Chem., Jyoti Resins, and Indo Amines.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vidhi Specialty, Nitta Gelatin, Platinum Industr, Excel Industries, Jyoti Resins, and the rest. Average management risk is found at S H Kelkar & Co., Indokem, Paushak, Oriental Aromat., Sunshield Chem., and Indo Amines. Below Average management risk is noted for Indokem. In terms of growth, Excellent growth is seen at Jyoti Resins, while Average growth is present at Nitta Gelatin and the rest. Below Average growth is noted for S H Kelkar & Co., Vidhi Specialty, Indokem, Platinum Industr, Excel Industries, Paushak, Oriental Aromat., Sunshield Chem., and Indo Amines. Excellent capital structure is found at Vidhi Specialty, Nitta Gelatin, Platinum Industr, Excel Industries, Jyoti Resins, while Average capital structure is observed at S H Kelkar & Co., Paushak, and Sunshield Chem., and Below Average capital structure is noted for Indokem and Oriental Aromat.<BR><BR>Return Snapshot: Indokem has the highest 1-year return at 121.35%, while S H Kelkar & Co. has the lowest at -50.71%. Paushak's 1-year return is -14.34%, which is higher than S H Kelkar & Co. but lower than Indokem. Additionally, the six-month return is negative for S H Kelkar & Co., Vidhi Specialty, Indokem, Platinum Industr, Excel Industries, and Indo Amines.

What does Paushak do?

Paushak Ltd is India's largest manufacturer of Phosgene-based specialty chemicals, part of the Alembic Group, with a market cap of INR 1,172 Cr and reported net sales of 55 Cr and net profit of 13 Cr for the quarter ending March 2026. Key financial metrics include a P/E ratio of 28.00 and a dividend yield of 0.56%.

Overview:<BR>Paushak Ltd is India's largest manufacturer of Phosgene-based specialty chemicals, operating within the micro-cap segment of the specialty chemicals industry.<BR><BR>History:<BR>Established in May 1972, Paushak Ltd is part of the Alembic Group, which has a legacy of over 115 years. The latest reported financial results are for the quarter ending March 2026, showcasing the company's performance in net sales and profit.<BR><BR>Financial Snapshot:<BR>- Net Sales: 55 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 13 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 1,172 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 28.00<BR>- Industry P/E: 29<BR>- Dividend Yield: 0.56%<BR>- Debt-Equity: 0.11<BR>- Return on Equity: 8.19%<BR>- Price to Book: 2.39<BR><BR>Contact Details:<BR>Address: 5th Floor Administration Buidg, Alembic Road Vadodara Gujarat : 390003<BR>Tel: 91-265-2280550<BR>Email: paushak.investors@alembic.co.in<BR>Website: http://www.paushak.com

Is Paushak technically bullish or bearish?

As of December 1, 2025, the trend is mildly bullish with daily moving averages supporting this view, but caution is advised due to bearish signals from the weekly MACD and Bollinger Bands, despite some bullish indicators in the monthly MACD.

As of 1 December 2025, the technical trend has changed from sideways to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating a positive trend. However, the weekly MACD remains bearish, which suggests caution. The monthly MACD is mildly bullish, providing some support for the overall bullish outlook. The Bollinger Bands are bearish across both weekly and monthly time frames, indicating potential volatility. The KST shows a mixed picture with weekly mildly bearish and monthly mildly bullish readings. Overall, while there are some bullish indicators, the presence of bearish signals in the MACD and Bollinger Bands suggests a cautious approach.

How has been the historical performance of Paushak?

Paushak's historical performance shows a slight decline in net sales and operating profit from Mar'23 to Mar'25, with profit after tax decreasing to 49.38 Cr. Despite increased total assets, rising liabilities and decreased cash flow from operating activities indicate potential liquidity challenges.

Answer:<BR>The historical performance of Paushak shows a fluctuating trend in net sales, with a peak of 212.35 Cr in Mar'23, followed by a slight decline to 210.95 Cr in Mar'25. The total operating income has mirrored this trend, reaching 212.35 Cr in Mar'23 and settling at 210.95 Cr in Mar'25. Raw material costs have decreased from 48.24 Cr in Mar'23 to 43.43 Cr in Mar'25, while employee costs have risen from 26.77 Cr in Mar'23 to 35.48 Cr in Mar'25. Operating profit (PBDIT) has shown a decline from 84.24 Cr in Mar'23 to 73.89 Cr in Mar'25, with the operating profit margin decreasing from 35.41% to 28.28%. Profit before tax also decreased from 72.22 Cr in Mar'23 to 58.78 Cr in Mar'25, leading to a profit after tax of 49.38 Cr in Mar'25, down from 54.01 Cr in Mar'23. The company's total assets have increased from 414.74 Cr in Mar'23 to 571.98 Cr in Mar'25, while total liabilities have also risen from 481.35 Cr to 571.98 Cr in the same period. Cash flow from operating activities has decreased from 56.00 Cr in Mar'24 to 37.00 Cr in Mar'25, indicating a tightening cash position.<BR><BR>Breakdown:<BR>Paushak's net sales have shown a slight decline from 212.35 Cr in Mar'23 to 210.95 Cr in Mar'25, while total operating income has followed a similar pattern. Raw material costs decreased significantly, contributing to a lower operating profit (PBDIT) of 73.89 Cr in Mar'25 compared to 84.24 Cr in Mar'23. The operating profit margin has also decreased, reflecting rising employee costs. Profit before tax has decreased to 58.78 Cr in Mar'25 from 72.22 Cr in Mar'23, resulting in a profit after tax of 49.38 Cr. The company's total assets have increased substantially, indicating growth, but total liabilities have risen correspondingly, suggesting increased financial obligations. Cash flow from operating activities has decreased, highlighting potential liquidity challenges.

Who are the top shareholders of the Paushak?

The top shareholders of Paushak include Nirayu Limited with 41.15%, individual investors with 25.23%, and three foreign institutional investors holding 0.01%. There are no mutual funds or public shareholders among the top holdings.

The top shareholders of Paushak include the promoters, with Nirayu Limited holding the largest stake at 41.15%. Additionally, individual investors collectively own 25.23% of the company. There are also three foreign institutional investors (FIIs) that hold a very small percentage, specifically 0.01%. Notably, there are no mutual funds currently invested in Paushak, and there are no public shareholders listed among the top holdings.

Is Paushak overvalued or undervalued?

As of April 9, 2020, Paushak is considered very expensive and overvalued with a PE Ratio of 27.25, elevated compared to industry norms, and has underperformed against the Sensex, declining 11.69% year-to-date while the Sensex gained 5.63%.

As of 9 April 2020, the valuation grade for Paushak has moved from expensive to very expensive, indicating a significant shift in its market perception. The company is currently considered overvalued. Key ratios supporting this conclusion include a PE Ratio of 27.25, an EV to EBITDA of 22.83, and a Price to Book Value of 2.89, all of which are elevated compared to industry norms.<BR><BR>In comparison to its peers, Paushak's valuation stands out as particularly high; for instance, P I Industries has a PE Ratio of 35.59 and Bayer CropScience has a PE Ratio of 43.48, both of which are in the very expensive category, yet they still exceed Paushak's valuation metrics. Additionally, UPL, categorized as attractive, has a PE Ratio of 38.74, further highlighting the disparity. Notably, Paushak has underperformed against the Sensex over various time frames, including a year-to-date decline of 11.69% compared to the Sensex's gain of 5.63%, reinforcing the view that the stock is overvalued.

Has Paushak declared dividend?

Paushak Ltd has declared a 200% dividend, amounting to ₹20 per share, with an ex-date of July 26, 2024. While the company shows a positive 5-year total return of 104.37%, shorter-term returns have been negative, reflecting mixed performance overall.

Paushak Ltd has declared a 200% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 20<BR>- Ex-date: 26 Jul 24<BR><BR>Dividend Yield: 0.48%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -18.16%, with a dividend return of 0%, resulting in a total return of -18.16%.<BR><BR>Over the past year, the price return was -14.15%, with a dividend return of 0.36%, leading to a total return of -13.79%.<BR><BR>In the 2-year period, the price return was -35.43%, while the dividend return was 0.53%, culminating in a total return of -34.9%.<BR><BR>For the 3-year period, the price return was -53.5%, with a dividend return of 0.56%, resulting in a total return of -52.94%.<BR><BR>In the last 4 years, the price return was -43.08%, and the dividend return was 0.79%, leading to a total return of -42.29%.<BR><BR>Over the 5-year period, the price return was 102.04%, with a dividend return of 2.33%, resulting in a total return of 104.37%.<BR><BR>Overall, while Paushak Ltd has declared a significant dividend, the total returns over various periods show a mixed performance, with substantial losses in the shorter terms but a positive return over the longer 5-year period.